Prognostic Value of Baseline Immune Suppressive Biomarkers to Select Non-Small Cell Lung Cancer (NSCLC) Patients (pts) Likely to Benefit from the Plinabulin/docetaxel (plin/doc) Combination
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined